Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-02-18

Clinical Trial Update: Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the drug-drug interaction between mitiglinide and gemfibrozil in adults with type 2 diabetes; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemfibrozil (Gemfibrozil)
  • Mitiglinide (mitiglinide)

Snippet

Sponsor: Elixir Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED